Home Home Home Inbox Home Search

Event

Differences in Healthcare Resource Use and Costs Between Post-Discharge Chronic Obstructive Pulmonary Disease Patients Treated with Dry-Powder Inhalers and Pressurized Metered-Dose Inhalers [Board No. P1409]

Location: Board no. P1409
Session Type: Thematic Poster Session
Tuesday
May
22
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Eric T. Wittbrodt

Pharm.D., M.P.H.
AstraZeneca

Kristin Evans

Ph.D.
Truven Health Analytics, an IBM Company

Joseph Tkacz

M.S.
Truven Health Analytics, an IBM Company

Machaon Bonafede

Ph.D.
Truven Health Analytics, an IBM Company

Lauren Millette

Ph.D.
AstraZeneca

Gary T. Ferguson

MD
Pulmonary Research Institute of Southeast Michigan

View Abstract

Differences in Healthcare Resource Use and Costs Between Post-Discharge Chronic Obstructive Pulmonary Disease Patients Treated with Dry-Powder Inhalers and Pressurized Metered-Dose Inhalers

Parent Sessions

  • C42 - CONTEMPORARY TOPICS IN COPD
    05-22-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search